MICHAEL D WEST Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL D WEST.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL D WEST. MICHAEL D WEST is Chief Executive Officer in BIOTIME INC ($BTX) and Co-Chief Executive Officer in BIOTIME INC ($BTX) and Director in BIOTIME INC ($BTX) and Director in OncoCyte Corp ($OCX) and Chief Executive Officer in AgeX Therapeutics, Inc. ($AGE).
Latest Insider Trading Transactions of MICHAEL D WEST
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 08 2021 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | A | 1.45 | 120,000 | 174,000 | 120,000 | |
Mar 15 2021 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 25,000 | |
Mar 15 2021 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 2.03 | 1,284 | 2,607 | 32,439 | 33.7 K to 32.4 K (-3.81 %) |
Mar 15 2021 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 3,125 | 0 | 33,723 | 30.6 K to 33.7 K (+10.21 %) |
Dec 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 28,125 | |
Dec 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 1.69 | 1,081 | 1,827 | 30,598 | 31.7 K to 30.6 K (-3.41 %) |
Dec 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 3,125 | 0 | 31,679 | 28.6 K to 31.7 K (+10.94 %) |
Dec 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 28,125 | |
Dec 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 1.69 | 1,081 | 1,827 | 30,598 | 31.7 K to 30.6 K (-3.41 %) |
Dec 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 3,125 | 0 | 31,679 | 28.6 K to 31.7 K (+10.94 %) |
Sep 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 31,250 | |
Sep 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 0.81 | 1,081 | 875 | 28,554 | 29.6 K to 28.6 K (-3.65 %) |
Sep 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 3,125 | 0 | 29,635 | 26.5 K to 29.6 K (+11.79 %) |
Jun 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 34,375 | |
Jun 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 0.80 | 1,081 | 865 | 26,510 | 27.6 K to 26.5 K (-3.92 %) |
Jun 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 3,125 | 0 | 27,591 | 24.5 K to 27.6 K (+12.77 %) |
Jun 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 3,125 | 0 | 34,375 | |
Jun 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 0.80 | 1,081 | 865 | 26,510 | 27.6 K to 26.5 K (-3.92 %) |
Jun 15 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 3,125 | 0 | 27,591 | 24.5 K to 27.6 K (+12.77 %) |
Mar 13 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | M | 0.00 | 12,500 | 0 | 37,500 | |
Mar 13 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Payment of Exercise | F | 0.88 | 5,085 | 4,463 | 24,446 | 29.5 K to 24.4 K (-17.22 %) |
Mar 13 2020 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | M | 0.00 | 12,500 | 0 | 29,551 | 17.1 K to 29.6 K (+73.31 %) |
Mar 13 2019 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Mar 13 2019 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | A | 4.28 | 100,000 | 428,000 | 100,000 | |
Dec 12 2018 | AGE | AgeX Therapeutics, ... | WEST MICHAEL D | Chief Executive Off ... | Buy | P | 3.86 | 4,000 | 15,443 | 15,460 | 11.5 K to 15.5 K (+34.90 %) |
Sep 19 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 10,938 | 0 | 0 | |
Sep 19 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 10,938 | 0 | 0 | |
Sep 19 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 2.31 | 3,783 | 8,739 | 893,913 | 897.7 K to 893.9 K (-0.42 %) |
Sep 19 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 2.31 | 3,783 | 8,739 | 893,913 | 897.7 K to 893.9 K (-0.42 %) |
Sep 19 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 10,938 | 0 | 897,696 | 886.8 K to 897.7 K (+1.23 %) |
Sep 19 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 10,938 | 0 | 897,696 | 886.8 K to 897.7 K (+1.23 %) |
Jul 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 1,562 | 0 | 10,938 | |
Jul 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 2.20 | 541 | 1,190 | 886,758 | 887.3 K to 886.8 K (-0.06 %) |
Jul 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 1,562 | 0 | 887,299 | 885.7 K to 887.3 K (+0.18 %) |
Jul 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 1,562 | 0 | 10,938 | |
Jul 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 2.20 | 541 | 1,190 | 886,758 | 887.3 K to 886.8 K (-0.06 %) |
Jul 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 1,562 | 0 | 887,299 | 885.7 K to 887.3 K (+0.18 %) |
Apr 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 1,563 | 0 | 12,500 | |
Apr 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 2.49 | 541 | 1,347 | 885,737 | 886.3 K to 885.7 K (-0.06 %) |
Apr 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 1,563 | 0 | 886,278 | 884.7 K to 886.3 K (+0.18 %) |
Jan 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 1,562 | 0 | 14,063 | |
Jan 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 2.68 | 686 | 1,838 | 884,715 | 885.4 K to 884.7 K (-0.08 %) |
Jan 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 1,562 | 0 | 885,401 | 883.8 K to 885.4 K (+0.18 %) |
Oct 12 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 1,563 | 0 | 15,625 | |
Oct 12 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 2.81 | 588 | 1,652 | 883,839 | 884.4 K to 883.8 K (-0.07 %) |
Oct 12 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 1,563 | 0 | 884,427 | 882.9 K to 884.4 K (+0.18 %) |
Aug 23 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | P | 2.60 | 2,000 | 5,198 | 882,864 | 880.9 K to 882.9 K (+0.23 %) |
Jul 12 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 1,562 | 0 | 17,188 | |
Jul 12 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 3.09 | 587 | 1,814 | 880,864 | 881.5 K to 880.9 K (-0.07 %) |
Jul 12 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 1,562 | 0 | 881,451 | 879.9 K to 881.5 K (+0.18 %) |
May 01 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 6,250 | 0 | 18,750 | |
May 01 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 3.33 | 2,348 | 7,819 | 879,889 | 882.2 K to 879.9 K (-0.27 %) |
May 01 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 6,250 | 0 | 882,237 | 876 K to 882.2 K (+0.71 %) |
Feb 18 2016 | OCX | OncoCyte Corp | WEST MICHAEL D | Director | Option Exercise | A | 3.06 | 60,000 | 183,600 | 60,000 | |
Apr 11 2016 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Apr 11 2016 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | A | 3.16 | 175,000 | 553,000 | 175,000 | |
Jul 14 2015 | BTX | BIOTIME INC | WEST MICHAEL D | Chief Executive Off ... | Option Exercise | A | 3.51 | 200,000 | 702,000 | 200,000 | |
Apr 07 2004 | BTX | BIOTIME INC | WEST MICHAEL D | Director | Option Exercise | A | 2.17 | 20,000 | 43,400 | 20,000 |
Page: 1